The Parliamentary Standing Committee on Health and Family Welfare, in its 176th Report, highlighted the growing disparity between private and public healthcare costs and raised concerns regarding affordability, regulation, and the impact of corporatisation in India’s healthcare sector. For aspirants preparing for competitive examinations, UPSC coaching in Hyderabad .
Policy Contradictions
- Standardised package rates and mandatory pre-treatment cost estimates for transparency.
2. Linking room tariffs in private hospitals to nearby three-star hotel rates.
3. Cross-subsidisation by corporate hospitals to reserve regulated beds for Ayushman Bharat
(AB-PMJAY) beneficiaries.
4. India seeks greater private and foreign capital in Tier-2/3 cities, yet is reviewing FDI rules for
hospital acquisitions, creating uncertainty for investors.
5. Currently, India allows 100% FDI under the automatic route in hospitals, which has helped
India emerge as a global medical destination, but the Committee warns of rising costs due to
aggressive corporatisation.
Role of Private Investment
- Hospitals demand high capital investment for land, ICUs, advanced equipment, laboratories,
and skilled personnel.
2. Public hospitals alone cannot meet the demand for secondary and tertiary care.
3. Private and foreign investors bring capital, technology, and managerial expertise, bridging
gaps in infrastructure.
4. India’s healthcare sector recorded ₹10,000 crore worth of deals in Q2 FY26, including hospital
acquisitions, diagnostics, and specialty care.
5. Leading hospital chains plan to add 18,000+ beds over the next 3–5 years, through greenfield
projects and acquisitions.
FDI Trends in Healthcare
- India received USD 58.8 billion FDI equity inflows in FY 2025–26, a growth of 18% over the
previous year.
2. Top contributors: Singapore (25%), Mauritius (24%), and the USA (10%).
3. Healthcare remains a preferred sector for private equity and foreign investors due to high
demand for specialty care and diagnostics.
Concerns of Incentive Structures
- In health care, providers possess far more knowledge than patients, creating a situation where
patients depend heavily on doctors’ judgments.
2. Strong revenue pressures can influence the volume and type of care delivered, sometimes
beyond medical necessity.
3. Corporate hospitals, backed by private equity, face pressure to recover costs through high
salaries, advanced equipment, and strict revenue targets.
4. This environment can lead to over-medicalisation unnecessary tests, prolonged admissions,
or procedures such as caesarean deliveries and angioplasties, driven more by institutional
incentives than patient need.
FDI and Regulation
- Review of FDI in hospital acquisitions is justified.
2. Key questions: Does investment create new capacity or merely acquire existing assets?
3. Greenfield investments should be encouraged; acquisitions must avoid market concentration
and excessive pricing.
4. Public concessions (land, tax benefits) must link to affordable beds and insurance
participation.
Strengthening Public Health
- Beyond Regulation: India cannot rely solely on price caps or FDI reviews; public hospitals must
be strengthened to provide a credible alternative to private care.
2. Primary Health Care Focus: Greater emphasis is needed on prevention, early detection, and
timely treatment, reducing the burden on tertiary facilities.
3. Insurance Reform: Schemes like Ayushman Bharat–PMJAY should incentivise appropriate and
necessary care, rather than rewarding higher volumes of procedures.
4. Clinical Safeguards: Evidence-based protocols, clinical audits, and transparent billing
systems can protect both patients and doctors from commercial pressures and unnecessary
interventions.
Conclusion
India’s private health-care boom bridges gaps but raises affordability and ethical concerns. Regulation,
FDI scrutiny, and pricing reforms matter, yet strengthening public systems ensures medical priorities
over profit motives.
